The European Union exercised its option for a further 100 million doses of Pfizer Inc. and BioNTech SE’s Covid-19 vaccine, raising its order from the companies to 600 million doses.
The boost makes the EU deal the partners’ biggest yet, and they’ll aim to deliver all the doses this year, Sean Marett, BioNTech’s chief business and commercial officer, said in a statement. The option to buy an extra 100 million doses was part of a purchase agreement the 27-nation bloc signed with Pfizer and BioNTech in February.